BMY Bristol Myers RESULTS: Q2, Q2 REV $12.97B vs EST $11.75B, Q2 ADJ EPS $2.04 vs EST $1.59, Bristol Myers Earnings Notes:, Outlook FY REV a

BMY Bristol Myers RESULTS: Q2, Q2 REV $12.97B vs EST $11.75B, Q2 ADJ EPS $2.04 vs EST $1.59, Bristol Myers Earnings Notes:, Outlook FY REV about $49B to $50B vs EST $47.47B, Outlook FY ADJ EPS $6.75 to $7 vs EST $6.34, Outlook FY eliquis REV growth 20%-25% vs prior forecast of 10%-15%